Sanna Sillankorva is a Research Fellow at INL funded by Marie-Curie COFUND. She works in the Department of Life Science within the Nano4Health group. Her project relies on the development of a novel topical bacteriophage delivery system.
She holds a PhD degree in Chemical and Biological Engineering from the University of Minho, Portugal, that included visiting periods both at the Universities of Oulu and Helsinki in Finland. Her PhD focused on the use of bacteriophages to control bacterial biofilms. She was a postdoctoral researcher (2009-2013) at the Centre of Biological Engineering of the University of Minho, and recipient of a 2013 FCT Investigator grant (2013-2018) that focused on the prevention and control of food and clinically relevant pathogens. She has coordinated 3 national projects, edited 2 hard-cover books and 1 eBook, published over 50 articles, and over 10 book chapters, and supervised over 25 postdoctoral, PhD and MSc researchers.
- Pinto AM, Cerqueira MA, Bañobre-Lopes M, Pastrana LM, Sillankorva S.
Bacteriophages for chronic wound treatment: from traditional to novel delivery systems
Viruses, Feb 2020, 12(2), 235, 10.3390/v12020235
- Alves D, Cerqueira MA, Pastrana L, Sillankorva S.
Entrapment of a phage cocktail and cinnamaldehyde on sodium alginate emulsion-based films to fight food contamination by Escherichia coli and Salmonella Enteritidis
Food Research International, Feb 2020, 128, 108791, https://doi.org/10.1016/ j.foodres.2019.108791
- Milho C, Silva MD, Alves D, Oliveira H, Sousa C, Pastrana LM, Azeredo J, Sillankorva S.
Escherichia coli and Salmonella Enteritidis dual-species biofilms: interspecies interactions and antibiofilm efficacy of phages
Scientific Reports, Dec 2019, 9(1):18183, doi: 10.1038/s41598-019-54847-y
- Silva MD, Sillankorva S (2019)
Otitis media pathogens – A life entrapped in biofilm communities
Critical Reviews in Microbiology. Sept 2019, 10:1-18. doi: 10.1080/1040841X.2019.1660616
- Milho C, Andrade M, Vilas Boas D, Alves D, Sillankorva S.
Antimicrobial assessment of phage therapy using a porcine model of biofilm infection.
Int J Pharm. 2019 Feb, 25;557:112-123. doi: 10.1016/j.ijpharm.2018.12.004. Epub 2018 Dec 25.